In a phase II trial, adults with a BMI of 30 or 27 kg/m with comorbidities were randomized to receive efpeglenatide at doses of 4 mg weekly, 6 mg weekly, 6 mg biweekly, or 8 mg biweekly, or a placebo, all combined with a hypocaloric diet [17]
Supplements and Blood Pressure May 10, 2024 increase or decrease blood pressure, and learn what to look for when selecting a home blood pressure monitor, in our article about supplements and blood pressure
and other large, wealthy OECD nations
Some protocols describe localized subcutaneous injection near the area of interest
The single-dose toxicity study revealed no test-related effects in the organs of treated animals, further supporting its safety
It produces little to no skin irritation